Neo7Bioscience Takes the Lead in Collaboration with Serokell and Knowledge Graph Developer Elsevier to Revolutionize Molecular Research and Peptide Engineering for Precision and Personalized Medicine
This strategic alliance aims to revolutionize bioinformatics, molecular target analysis, and peptide engineering, focusing on advancing precision and personalized medicine.
- This strategic alliance aims to revolutionize bioinformatics, molecular target analysis, and peptide engineering, focusing on advancing precision and personalized medicine.
- Neo7Bioscience, leveraging its profound expertise in molecular analytics and peptide engineering, spearheads the path for revolutionary breakthroughs in personalized therapeutics.
- Elsevier, the developer of the knowledge graph, is a key partner in this endeavor, integrating the combined efforts of Neo7Bioscience and Serokell into its knowledge graph bioinformatics platform.
- Neo7Bioscience, Serokell, and Elsevier are poised to revolutionize the molecular research and peptide engineering landscape, ushering in more efficient and tailored solutions for precision and personalized medicine.